348 related articles for article (PubMed ID: 33403354)
1. Gene Therapy for Primary Immunodeficiency.
Houghton BC; Booth C
Hemasphere; 2021 Jan; 5(1):e509. PubMed ID: 33403354
[TBL] [Abstract][Full Text] [Related]
2. Treating Immunodeficiency through HSC Gene Therapy.
Booth C; Gaspar HB; Thrasher AJ
Trends Mol Med; 2016 Apr; 22(4):317-327. PubMed ID: 26993219
[TBL] [Abstract][Full Text] [Related]
3. Overview of the current status of gene therapy for primary immune deficiencies (PIDs).
Kuo CY; Kohn DB
J Allergy Clin Immunol; 2020 Aug; 146(2):229-233. PubMed ID: 32771134
[TBL] [Abstract][Full Text] [Related]
4. Preclinical Development of a Hematopoietic Stem and Progenitor Cell Bioengineered Factor VIII Lentiviral Vector Gene Therapy for Hemophilia A.
Doering CB; Denning G; Shields JE; Fine EJ; Parker ET; Srivastava A; Lollar P; Spencer HT
Hum Gene Ther; 2018 Oct; 29(10):1183-1201. PubMed ID: 30160169
[TBL] [Abstract][Full Text] [Related]
5. Progress in gene therapy for primary immunodeficiencies using lentiviral vectors.
Sauer AV; Di Lorenzo B; Carriglio N; Aiuti A
Curr Opin Allergy Clin Immunol; 2014 Dec; 14(6):527-34. PubMed ID: 25207699
[TBL] [Abstract][Full Text] [Related]
6. Ten years of gene therapy for primary immune deficiencies.
Aiuti A; Roncarolo MG
Hematology Am Soc Hematol Educ Program; 2009; ():682-9. PubMed ID: 20008254
[TBL] [Abstract][Full Text] [Related]
7. Historical Perspective on the Current Renaissance for Hematopoietic Stem Cell Gene Therapy.
Kohn DB
Hematol Oncol Clin North Am; 2017 Oct; 31(5):721-735. PubMed ID: 28895843
[TBL] [Abstract][Full Text] [Related]
8. The changing landscape of gene editing in hematopoietic stem cells: a step towards Cas9 clinical translation.
Dever DP; Porteus MH
Curr Opin Hematol; 2017 Nov; 24(6):481-488. PubMed ID: 28806273
[TBL] [Abstract][Full Text] [Related]
9. The Immune Response to the fVIII Gene Therapy in Preclinical Models.
Patel SR; Lundgren TS; Spencer HT; Doering CB
Front Immunol; 2020; 11():494. PubMed ID: 32351497
[TBL] [Abstract][Full Text] [Related]
10. Gene therapy for inherited immunodeficiency.
Touzot F; Hacein-Bey-Abina S; Fischer A; Cavazzana M
Expert Opin Biol Ther; 2014 Jun; 14(6):789-98. PubMed ID: 24823313
[TBL] [Abstract][Full Text] [Related]
11. Gene therapy for primary immunodeficiency.
Booth C; Romano R; Roncarolo MG; Thrasher AJ
Hum Mol Genet; 2019 Oct; 28(R1):R15-R23. PubMed ID: 31297531
[TBL] [Abstract][Full Text] [Related]
12. Gene therapy and genome editing for primary immunodeficiency diseases.
Zhang ZY; Thrasher AJ; Zhang F
Genes Dis; 2020 Mar; 7(1):38-51. PubMed ID: 32181274
[TBL] [Abstract][Full Text] [Related]
13. Lentiviral hematopoietic stem cell gene therapy in patients with Wiskott-Aldrich syndrome.
Aiuti A; Biasco L; Scaramuzza S; Ferrua F; Cicalese MP; Baricordi C; Dionisio F; Calabria A; Giannelli S; Castiello MC; Bosticardo M; Evangelio C; Assanelli A; Casiraghi M; Di Nunzio S; Callegaro L; Benati C; Rizzardi P; Pellin D; Di Serio C; Schmidt M; Von Kalle C; Gardner J; Mehta N; Neduva V; Dow DJ; Galy A; Miniero R; Finocchi A; Metin A; Banerjee PP; Orange JS; Galimberti S; Valsecchi MG; Biffi A; Montini E; Villa A; Ciceri F; Roncarolo MG; Naldini L
Science; 2013 Aug; 341(6148):1233151. PubMed ID: 23845947
[TBL] [Abstract][Full Text] [Related]
14. Lentiviral hematopoietic cell gene therapy for X-linked adrenoleukodystrophy.
Cartier N; Hacein-Bey-Abina S; Bartholomae CC; Bougnères P; Schmidt M; Kalle CV; Fischer A; Cavazzana-Calvo M; Aubourg P
Methods Enzymol; 2012; 507():187-98. PubMed ID: 22365775
[TBL] [Abstract][Full Text] [Related]
15. Gene therapy for primary immunodeficiencies.
Kildebeck E; Checketts J; Porteus M
Curr Opin Pediatr; 2012 Dec; 24(6):731-8. PubMed ID: 23073463
[TBL] [Abstract][Full Text] [Related]
16. Enhanced Transduction of
Sii-Felice K; Castillo Padilla J; Relouzat F; Cheuzeville J; Tantawet S; Maouche L; Le Grand R; Leboulch P; Payen E
Hum Gene Ther; 2019 Oct; 30(10):1306-1323. PubMed ID: 30848170
[TBL] [Abstract][Full Text] [Related]
17. Laboratory-Scale Lentiviral Vector Production and Purification for Enhanced
Soldi M; Sergi Sergi L; Unali G; Kerzel T; Cuccovillo I; Capasso P; Annoni A; Biffi M; Rancoita PMV; Cantore A; Lombardo A; Naldini L; Squadrito ML; Kajaste-Rudnitski A
Mol Ther Methods Clin Dev; 2020 Dec; 19():411-425. PubMed ID: 33294490
[TBL] [Abstract][Full Text] [Related]
18. [Development of gene therapy for hematopoietic stem cell using viral vectors].
Dong WJ; Zu ZX; Liu DP; Liang CC
Yi Chuan Xue Bao; 2003 Apr; 30(4):382-8. PubMed ID: 12812066
[TBL] [Abstract][Full Text] [Related]
19. Answered and Unanswered Questions in Early-Stage Viral Vector Transduction Biology and Innate Primary Cell Toxicity for
Dudek AM; Porteus MH
Front Immunol; 2021; 12():660302. PubMed ID: 34122418
[TBL] [Abstract][Full Text] [Related]
20. Lentiviral haemopoietic stem/progenitor cell gene therapy for treatment of Wiskott-Aldrich syndrome: interim results of a non-randomised, open-label, phase 1/2 clinical study.
Ferrua F; Cicalese MP; Galimberti S; Giannelli S; Dionisio F; Barzaghi F; Migliavacca M; Bernardo ME; Calbi V; Assanelli AA; Facchini M; Fossati C; Albertazzi E; Scaramuzza S; Brigida I; Scala S; Basso-Ricci L; Pajno R; Casiraghi M; Canarutto D; Salerio FA; Albert MH; Bartoli A; Wolf HM; Fiori R; Silvani P; Gattillo S; Villa A; Biasco L; Dott C; Culme-Seymour EJ; van Rossem K; Atkinson G; Valsecchi MG; Roncarolo MG; Ciceri F; Naldini L; Aiuti A
Lancet Haematol; 2019 May; 6(5):e239-e253. PubMed ID: 30981783
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
